Insulet Corp (PODD) Stock Price & Analysis

Insulet Corp (PODD) rose 0.00% to USD 163.26 as of July 25, 2026 at 01:46 UTC, according to Nexqual real-time market data.

PODD last closed at USD 163.26; the session ranged USD 158.31–164.33 on volume of 1,138,681 shares. Market capitalization is —, with a 52-week range of USD 138.79–354.88 (NMS). Source: Nexqual, July 25, 2026 at 01:46 UTC.

Key Statistics (as of July 25, 2026 at 01:46 UTC)

Technical Analysis (PODD)

Nexqual's technical model rates PODD "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 01:46 UTC.

From Insulet Corp's Latest SEC 10-K Filing (filed 2026-02-18)

Key Strengths & Strategy (as disclosed to the SEC)

• As a medical device manufacturer and distributor, our manufacturing facilities and the facilities of our suppliers are subject to periodic inspection by the FDA, certain corresponding state agencies, and other regulatory bodies. 7 Table of Contents Intellectual Property To maintain a competitive advantage, we believe we must develop and preserve the proprietary aspect of our technologies.
• Our Omnipod platform's unique patented design allows us to provide Pod therapy at a relatively low or no up-front investment, which reduces the risk to third-party payors in the United States.
• We rely on a combination of copyright, patent, trademark, trade secret, and other intellectual property laws, non-disclosure agreements, and other measures to protect our proprietary rights.
• Patents As of December 31, 2025, we had over 1,000 patents in the United States and certain other countries, with expiration dates ranging from 2026 through 2047 and had over 700 patent applications pending.

Partnerships

• Data Management We have partnered with Glooko Inc. ("Glooko") to connect user data with Glooko's comprehensive diabetes data management system (including Diasend in selected regions).

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:46 UTC. This page is informational and not investment advice.